Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
The protein encoded by TMPRSS6 is a type II transmembrane serine proteinase that is found attached to the cell surface. Additionally we are shipping TMPRSS6 Kits (6) and TMPRSS6 Proteins (6) and many more products for this protein.
Showing 10 out of 41 products:
Human Polyclonal TMPRSS6 Primary Antibody for WB - ABIN1881891
Altamura, DAlessio, Selle, Muckenthaler: A novel TMPRSS6 mutation that prevents protease auto-activation causes IRIDA. in The Biochemical journal 2010
Show all 2 references for ABIN1881891
Cow (Bovine) Polyclonal TMPRSS6 Primary Antibody for IHC, WB - ABIN2785278
Finberg, Heeney, Campagna, Aydinok, Pearson, Hartman, Mayo, Samuel, Strouse, Markianos, Andrews, Fleming: Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA). in Nature genetics 2008
Matriptase-2 deficiency causes iron deficiency anemia during the early postnatal development, but not during fetal development in humans.
Iron refractory iron deficiency anemia is caused by mutations of TMPRSS6 which encodes matriptase-2, a serine protease (show F2 Antibodies) expressed on cell membranes of hepatocytes which is involved in the hepcidin (show HAMP Antibodies) regulatory pathways by processing hemojuvelin (show HFE2 Antibodies) protein.
Combination of Tmprss6- ASO and the iron chelator deferiprone improves erythropoiesis and reduces iron overload in a mouse model of beta-thalassemia intermedia.
Data show that p.V736A TMPRSS6 variant (rs855791) influences the susceptibility to hepatic iron accumulation in NTDT patients, and the risk allele is 736(A).
A novel splicing mutation of TMPRSS6 exon 9 (c.1113G>A) was found in an iron-refractory iron deficiency anemia patient and his father.
N-glycan branching regulates HAI-2 (show SPINT2 Antibodies) through different subcellular distribution and subsequently access to different target proteases
Data show that transmembrane serine protease (show F2 Antibodies) TMPRSS6 cleaves both the heterodimeric and the full-length mutant hemojuvelin (show HFE2 Antibodies) (m-HJV (show HFE2 Antibodies)).
genetic association studies in a population of black women in South Africa: Data suggest that SNPs in TMPRSS6 (rs228918; rs228921) are associated with iron status/iron-deficiency anemia in the population studied.
We confirm that TMPRSS6 mutations are spread along the gene and that mechanistically they fully or partially abrogate hepcidin (show HAMP Antibodies) inhibition.
Certain domains of matriptase-2 are important for trafficking to the cell surface and are required for cleavage of hemojuvelin (show HFE2 Antibodies).
role of fetuin-A (show AHSG Antibodies) in iron homeostasis and provide new insights into the mechanism of how matriptase-2 might modulate hepcidin (show HAMP Antibodies) expression
TMPRSS6 inhibition via decreased STAT5 (show STAT5A Antibodies) phosphorylation may be an additional mechanism by which inflammation stimulates hepcidin (show HAMP Antibodies) expression to regulate iron homeostasis and immunity.
matriptase-2 (encoded by Tmprss6)-is responsible for hepcidin (show HAMP Antibodies) repression throughout development, with its deficiency leading to increased hepcidin (show HAMP Antibodies) levels triggering iron deficiency and anemia starting in utero
The iron-regulatory serine protease (show F2 Antibodies) matriptase-2 is expressed in the retina, and absence of this enzyme leads to iron deficiency.
Loss of matriptase-2 increases bone morphogenetic protein-dependent signaling, while paradoxically decreasing liver hemojuvelin (show HFE2 Antibodies) protein content.
Results confirm the anti-inflammatory status of Tmprss6 KO mice and identify new potential target pathways/genes of Tmprss6.
Tmprss6 gene knockdown reduces iron overload in an animal model of hemochromatosis (show HFE Antibodies) and improves both iron overload and anemia in mice affected by beta-thalassemia.
Double mutant mice lacking functional Hfe (show HFE Antibodies) or Tfr2 (show TFR2 Antibodies) and Tmprss6 exhibited a severe iron deficiency microcytic anemia phenotype mimicking the phenotype of single mutant mice lacking functional Tmprss6 demonstrating that Hfe (show HFE Antibodies) and Tfr2 (show TFR2 Antibodies) are not substrates for Tmprss6.
Preventing iron overload improves beta-thalassemia and strengthens the essential role of Tmprss6 for Hamp (show HAMP Antibodies) suppression, providing a proof of concept that Tmprss6 manipulation can offer a novel therapeutic option in this condition.
The data do not provide support for the concept that matriptase-2 cleaves membrane hemojuvelin (show HFE2 Antibodies) and may indicate that, in vivo, the role of matriptase-2 in the regulation of hepcidin (show HAMP Antibodies) gene expression is more complex.
The protein encoded by this gene is a type II transmembrane serine proteinase that is found attached to the cell surface. The encoded protein may be involved in matrix remodeling processes in the liver.
transmembrane protease serine 6
, transmembrane serine protease 6
, membrane-bound mosaic serine proteinase matriptase-2
, type II transmembrane serine protease 6
, matriptase 2
, transmembrane protease, serine 6